Publications Office of the EU
Bevacizumab [2024–2026] - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Bevacizumab [2024–2026]

  • Published
    12/07/2024
  • Deadline
    12/08/2024
  • Opening of tenders
    12/08/2024
  • Awarded
    16/09/2024
  • Today
    18/04/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Masarykův onkologický ústav
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ064 Jihomoravský kraj
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
15,000,000.00 CZK
Total final contract value (excluding VAT)
18,843,024.00 CZK
Tender reference number
MOU 488 901
Description

Předmětem veřejné zakázky jsou dodávky léčivého přípravku dle specifikace a za podmínek uvedených v přílohách č. 2 (Specifikace veřejné zakázky) a č. 3 (Vzor kupní smlouvy) zadávací dokumentace.

Submission Method
Electronic via:
https://www.egordion.cz/nabidkaGORDION/profilMOU
Tenders may be submitted
Electronic submission: required
https://www.egordion.cz/nabidkaGORDION/profilMOU
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
12/08/2024 10:00
Place of performance
Award method
Nabídková cena
Estimated value
15,000,000.00 CZK
Final contracted value
18,843,024.00 CZK
Award of contract
Official name: PROMEDICA PRAHA GROUP, a.s.
Postal address:
Town: Praha - Bubeneč
Postal code: 16000
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.